All lobbying filings

LMH Strategic Solutions

LMH Strategic Solutions filed a Q3 report for Travere Therapeutics, Inc. on October 20, 2025, reporting $20,000 in lobbying income.

Lobbying for Travere Therapeutics, Inc. · Biopharmaceutical company.

As filed: LMH STRATEGIC SOLUTIONS for TRAVERE THERAPEUTICS, INC.

All filings by LMH Strategic Solutions · Everything Travere Therapeutics, Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$20,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 1

ALANNA TEMME

Previously held: Legislative Director, U.S. Representative Jon Porter

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 1

Pharmacy

Monitored Most-Favored Nation (MFN) and international reference pricing proposals.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.